With patient diversity becoming increasingly important to biopharmaceutical stakeholders, Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of North Georgia Clinical Research (NGCR), an investigator site based in Woodstock, Georgia.
As a research provider for more than two decades, NGCR specializes in general medicine studies involving Alzheimer’s disease prevention, cardiovascular disease, diabetes, digestive conditions, pain, as well as men’s and women’s health indications.
North Georgia Clinical Research evaluates new therapies for many common medical problems that are faced by both women and men:
„We are focused on building a trusted reputation in the community for patients interested in clinical research opportunities and have received recognition as a top enrolling site across many clinical studies“.
